|4Feb 1, 8:30 PM ET

Pestrikova Irina 4

4 · ENDRA Life Sciences Inc. · Filed Feb 1, 2023

Insider Transaction Report

Form 4
Period: 2023-01-30
Pestrikova Irina
Senior Director, Finance
Transactions
  • Award

    Stock Options

    2023-01-30+8,0008,000 total
    Exercise: $4.02Exp: 2033-01-30Common Stock (8,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION